Compound ID | 3286
Synonym(s): WX-081 | WX 081 | WX081 | fudapirine
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; |
| Spectrum of activity: | Antimycobacterial |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Mycobacterium tuberculosis |
| Description: | Synthetic compound (diarylquinoline); analogue of bedaquiline; shows favourable pharmacokinetics and reduced toxicity than bedaquiline |
| Institute where first reported: | Shanghai Jiatan Pharmatech Co., Ltd |
| Year first mentioned: | 2022 |
| Highest developmental phase: | Phase 3 (NCT05824871) |
| Development status: | Active (as of 2024) |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/156777270 |
| Guide to Pharmacology: | fudapirine |
| Citation: | https://journals.asm.org/doi/10.1128/spectrum.02477-21 |